Table 1.
Regulators | Cancer type | Up- or down-regulated in tumor cells | Function | References |
---|---|---|---|---|
METTL3 | TGCT | Down-regulated | Positively correlates with infiltration of CD8+ T cells, CD4+ T cells, and NK cells | [69] |
METTL3 | CRC | Up-regulated |
Negatively correlates with infiltration of CD8+ T cells; Negatively correlates with IFN-γ, CXCL9, and CXCL10 secretion; Negatively correlates with the response to anti-PD-1 treatment |
[70] |
METTL3 | CC | Up-regulated | Positively correlates with the density of CD33+ MDSCs | [71] |
METTL3 | BC | Up-regulated | Negatively correlates with infiltration of CD8+ T cells, helper T cells, and activated NK cells; positively correlates with infiltration of M2 TAMs | [72] |
METTL3 | HCC | Up-regulated | Negatively correlates with infiltration of DCs | [73] |
METTL3 HNRNPC | HNSCC | Up-regulated | Positively correlates with the infiltration of CD4 naive T cells, CD4 memory-activated T cells and eosinophils | [74] |
METTL14 | BC | Down-regulated | Positively correlates with infiltrating levels of CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and DCs; negatively correlates with Treg cells | [77] |
METTL14 | ccRCC | Up-regulated | Negatively correlates with infiltration of Treg cells | [78] |
WTAP | GC | Up-regulated | Negatively correlates with T cell infiltration and T cell-related immune responses | [79] |
WTAP | EC | Up-regulated | Positively correlates with both the immuno-inhibitors and immuno-stimulators infiltration, such as myeloid DCs, T cells, neutrophils, Treg cells, and macrophages | [80] |
FTO | AML | Up-regulated | Positively correlates with immune evasion, and inhibits the cytotoxicity of T cells | [85] |
ALKBH5 | Melanoma | unknown | Positively correlates with Treg cell infiltration; ALKBH5 deletion enhances the efficacy of anti–PD-1 therapy | [88] |
ALKBH5 | ICC | unknown | Positively regulates PD-L1 expression in tumor cells and inhibits the expansion and cytotoxicity of T cells by PD-1/PD-L1 signaling | [89] |
YTHDF2 | LGG | unknown | Positively correlates with infiltration of B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and DCs | [92] |
YTHDF1 YTHDF2 |
NSCLC | Up-regulated | Positively correlates with tumor-infiltrating lymphocytes, including CD8+ T cells, FOXP3+ T cells, PD-1+ T cells, and CD45RO+ immune cells | [93] |
YTHDF2 | KIRC | Down-regulated | Positively correlates with infiltration of B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and DCs | [94] |
YTHDF1 | GC | Up-regulated | Negatively correlates with CD4+ cells and CD8+ T cells; positively correlates with MDSCs | [96] |
YTHDF1 | BC | Up-regulated | Negatively correlates with infiltration of CD4+ cells, CD8+ T cells, activated NK, and monocytes; positively correlates with infiltration of M1 macrophages | [97] |